Happy #GOLDENWEEK to our friends & #partners in #Japan! A special thought to 小野薬品工業株式会社, thank you for your recent visit Domain Therapeutics allowing to deepen our #collaboration efforts with ONO Pharma & Michel Bouvier to develop a #GPCR-based solution for #patients #metabolicdisease

Don't miss a unique opportunity to meet our CEO Neuville Pascal at #LSXworld Congress 2023, London, May 3-4 & learn about Domain Therapeutics #GPCR-based therapies & #precision research to unlock new possibilities in #cancer #drugdevelopment #partnering LSX Leaders

How can we increase cancer treatment success rate & cure more #patients?  Join Neuville Pascal at #Bioequity Europe 2023 for #presentation on our approach pioneering #GPCR #immunotherapies for #immunooncology: 15th of May / 10:10am / The Convention Centre Dublin Dublin #investments EBD Group BioCentury

Let’s race for #research against #sarcoma & rare types of #cancer in children & young adults, opportunity to make a donation to @BERGONIE33 & contribute to RHU Condor combining #precisionmedicine & #immunotherapies for more efficient therapeutic management of sarcoma #patients

Happy to inaugurate our new HQ with friends & partners from our #innovation ecosystem. At Domain Therapeutics we push the boundaries of science to unlock new possibilities in cancer while committing to #SustainableDevelopment. Our new building reflects that. Thank you all for your support.

June 5-8 I Domain Therapeutics team will attend BIO Convention 2023 in Boston. Reach out to learn more about our pipeline of best-in-class & first-in-class #GPCR-targeting assets in #immunooncology. #BIO2023 #DrugDevelopment #DrugDesign #PrecisionMedicine #Biotech

Hop on your bike for a greener planet! Kudos Team Domain for the effort on #auboulotavelo2023 & dedication to sustainability. Let's inspire others to join us on this eco-friendly journey. #sustainable #worklifebalance #Auboulotavelo Strasbourg.eu CADR67

Domain Therapeutics #ImmunotherapyMonth saw some major milestones. Our #pressday spotlighted our position as the "#GPCR company" in #immunooncology, unlocking the potential of GPCRs VS cancer. Nominations of DT-9045 & DT-7012 further confirmed our commitment to innovative #cancertreatments

🚲« Bike to work » June challenge is now over: 🎯Domain Therapeutics is in the top 10 ➡️ 9th out of 243 🛣️ Distance covered: nearly 10,000 km ❔ approximately 2.53 tons of CO2 emissions avoided = trip from Paris to La Réunion! Congratulations to the Team! CADR67 Strasbourg.eu #Cancer

Best-in-class also works for choirs! 👏 Congratulations to 24 Domain Therapeutics choristers for incredible performance at the solidarity concert organized by Les Blouses Roses at the home for elderly. Music can help many of us find comfort and inspiration. #cancertreatment #immunooncology

Sarcoma merits #precisionmedicine all year-round! At Domain Therapeutics, we take pride to be working with Pr Antoine Italiano, our leading partner in the RHU Condor against Sarcoma! Thank you, Pr Italiano, for your commitment to developing novel #immunotherapies #sarcomaawarenessmonth

The IPCMS warmly thanks Domain Therapeutics for its generous donation of laboratory materials, equipment and furniture, and assures that it will be used wisely!